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Abstract
Child health is a growing concern at the global level, as infectious diseases and preventable conditions claim
hundreds of lives of children under the age of five in low-income countries. Approximately 7.6 million children
under five years of age died in 2011, calculating to about 19 000 children each day and almost 800 every hour.
About 80 percent of the world’s under-five deaths in 2011 occurred in only 25 countries, and about half in only
five countries: India, Nigeria, Democratic Republic of the Congo, Pakistan and China. The implications and burden
of such statistics are huge and will have dire consequences if they are not corrected promptly. This paper reviews
essential interventions for improving child health, which if implemented properly and according to guidelines have
been found to improve child health outcomes, as well as reduce morbidity and mortality rates. It also includes
caregivers and delivery strategies for each intervention. Interventions that have been associated with a decrease in
mortality and disease rates include exclusive breastfeeding, complementary feeding strategies, routine
immunizations and vaccinations for children, preventative zinc supplementation in children, and vitamin A
supplementation in vitamin A deficient populations.
Introduction
In the past few years, an inordinate amount of effort has
been put in towards the achievement of the millennium
development goal (MDG) for child survival- MDG 4.
Though some countries are on MDG target to reduce
under-five mortality by two-thirds, the total number of
child deaths has actually increased in 13 countries [1].
On a more positive note, under-five mortality worldwide
has decreased from approximately 9.6 million in 2000 to
7.6 million in 2012 [2]. The death of 19,000 children
under age five every day in 2011 [2] is still a major con-
cern, which dictates that evaluations are necessary for
further improvement.
Around half of under-five deaths occur in only five coun-
tries: India, Nigeria, Democratic Republic of Congo, Paki-
stan and China [2]. The leading causes of death among
children under age five are pneumonia (18% of all under-
five deaths); preterm birth complications (14%); diarrhea
(11%); intrapartum related complications (complications
during birth; 9%); and malaria (7%) [2]. Most of these com-
plications are preventable with the correct interventions
being implemented. Another major factor leading to the
inability to meet proposed reduction in figures of child
mortality is the fact that most maternal and child health
programs do not reach the world’s poorest families [3]. For
children who need them the most, survival interventions
such as vaccination programs have showed incomplete
coverage. Some programs have shown tremendous success,
such as the increased coverage of measles vaccination,
which have resulted in a 92% reduction in measles mortal-
ity between 2000 and 2008 in sub-Saharan Africa [2]. Pro-
blems associated with lack of coverage include poorly
designed health care systems in the developing world
where a lack of resources including skilled workers are a
major concern [3]. In some low and middle income coun-
tries (LMICs), such as Pakistan or India, resistance or refu-
sals against vaccines that are deep rooted in social-cultural,
religious and political contexts as well as gender-based
decision-making in households are direct causes of the
high rates of disease burdens such as polio [4].
The aim of this review is to underscore the effectiveness
of essential child health interventions that have an alleged
impact on reducing child illnesses and improving child
survival and can be suitably delivered to resource limited
countries.
Methodology
The methodology has been described in detail elsewhere
[4]. In short, the review included all child health interven-
tions based on current World Health Organization
(WHO) guidelines and recent Lancet series which have an* Correspondence: zulfiqar.bhutta@aku.edu
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alleged impact on reducing child morbidity and mortality;
suitable for delivery in LMICs; and those that can be deliv-
ered through the health sector (community level up to the
referral level of health care) (Table 1). All relevant child-
birth and postnatal intervention reviews were identified
from the electronic databases such as the Cochrane data-
base of systematic reviews, the Cochrane database of
abstract reviews of effectiveness (DARE), the Cochrane
database of systematic reviews of randomized control trials
(RCT’s), and PubMed. The reference lists of the reviews
and recommendations from experts in the field were also
used as sources to obtain additional publications. The
principal focus was on the existing systematic reviews and
meta-analysis. Based on the efficiency of the interventions,
these were then classified in categories from A to E (where
A signified strongly beneficial effect while E indicated




Evidence suggests that the safest and most successful way
to assure proper growth and development in child is by
providing the infant with breast milk from the first hour
of birth [5-7]. Exclusive breastfeeding also protects the
newborn from various diseases such as respiratory infec-
tions and diarrhea, which can lead to insidious outcomes
for the newborn. Even though these protective effects of
breastfeeding have been stated for years, the duration of
exclusive breastfeeding is still far below its optimal level it
should be in most countries, both high income countries
(HICs) and LMICs. This review assessed the interventions
that provided counseling on the benefits of exclusive
breastfeeding in the neonatal period and at six months to
all pregnant mothers, either individually or in groups.
A review found increased rates of exclusive breastfeed-
ing in neonatal period (risk ratio (RR) 3.06; 95% confi-
dence interval (CI): 2.10, 4.45) as well as at 6 months (RR
1.86; 95%CI: 1.12, 3.09) on comparing individual counsel-
ing with routine care [8]. Group counseling, on the other
hand, resulted in higher exclusive breastfeeding rates both
during neonatal period (RR 3.95; 95%CI: 2.09, 7.44) and at
6 months (RR 4.49; 95%CI: 1.90, 10.63) [8]. Other inter-
ventions for improving exclusive breastfeeding included
providing health education for women of all feeding inten-
tions vs. standard care (RR 1.57; 95% CI: 1.15, 2.15), peer
support for women considering breastfeeding (RR 4.02;
95% CI: 2.63, 6.14) and breastfeeding promotion packs for
women of all feeding intentions (RR 0.93; 95% CI: 0.80,
1.08) [9].
Similar findings have been reported in a recent review
which indicated that educational interventions significantly
increased exclusive breastfeeding rates (EBF) rates at day 1
by 43% (RR 1.43; 95% CI: 1.09, 1.87), at <1 month by 30%
(RR 1.30; 95% CI: 1.19, 1.42) and at 1-5 months by 90%
(RR 1.90; 95% CI: 1.54, 2.34) [10]. Subgroup analyses
showed that individual counseling alone led to a 60%
increase in exclusive breastfeeding rates (RR 1.60; 95% CI:
1.04, 2.48) [10].
Promotion and support of continued breastfeeding and
complementary feeding
a) Continued breastfeeding
Growth faltering is a commonly observed phenomenon
in LMICs after about three months of age [11-13]. This
growth faltering has traditionally been attributed to three
factors: (1) the suggested inadequacy of energy intake
from breast milk alone after three or four months; (2) the
poor nutritional quality (i.e., low energy and micronutrient
content) of the weaning foods commonly introduced in
many developing countries; and (3) the adverse effects of
infection on energy intake and expenditure. The belief
that breast milk alone is nutritionally insufficient after
three or four months, combined with the fact that weaning
foods given in many LMICS are both nutritionally inade-
quate and contaminated, led to concern about the so-
called ’weanling’s dilemma’ [14,15]. Because breastfeeding
can be lifesaving in LMICs and the health benefits of
breastfeeding are widely acknowledged, opinions and
recommendations are strongly divided on the optimal
duration of exclusive breastfeeding.
A recent Cochrane review [16] found that infants who
are exclusively breastfed for six months experience less
morbidity from gastrointestinal infection than those who
are partially breastfed as of three or four months (RR 0.41;
95% CI: 0.21, 0.78), and no deficits have been demon-
strated in growth among infants from either developing or
developed countries who are exclusively breastfed for six
months or longer. Moreover the results from controlled
trials showed that exclusive versus mixed breast-feeding in
developing countries resulted in a monthly weight gain
from 4-6 months (MD 20.78g/month; 95% CI: -21.99,
63.54); and from 6-12 months (MD -2.62g/month; 95% CI:
-25.85, 20.62) and a hemoglobin concentration of <110 g/
dl (RR 1.20; 95% CI: 0.90, 1.58). The same review using
observational studies showed a monthly weight gain from
4-6 months (MD -10.10; 95% CI: -27.68, 7.48) and from
6-9 months (MD -6.0; 95% CI: -54.15, 42.15).
b) Education strategies on complementary feeding
support
Period of complementary feeding (CF) (from 6 to 24
months of age) is one of the most critical times for pre-
venting malnutrition [17]. Effect on growth is most evident
during this time [11] particularly during the first phase of
complementary feeding when foods of low nutrient density
begin to replace breast milk and rates of diarrheal illness
caused by food contamination are at their highest. This is
consistent with results of intervention trials showing that
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the greatest impact of food supplementation is seen among
children less than 2 years of age [18,19]. CF is a food-based
intervention, given at the age range of 6-24 months, along
with breastfeeding to fulfill the extra needs of the growing
infant. Several strategies can be used for promotion of this
intervention, such as education about CF as the main treat-
ment, and provision of complementary foods.
A recent review has reported that education on CF alone
significantly improved height-for-age Z score (HAZ) (stan-
dard mean difference (SMD): 0.23; 95% CI: 0.09, 0.36),
weight-for-age Z score (WAZ) (SMD 0.16, 95% CI: 0.05,
0.27), and significantly reduced the rates of stunting (RR
0.71; 95% CI: 0.56, 0.91, 5 studies); no significant impact
were observed for height and weight gain [20]. However,
based on the subgroup analysis; studies from food secure
populations indicated education on CF had a significant
impact on height gain (SMD 0.35; 95% CI: 0.08, 0.62),
HAZ scores (SMD 0.22; 95% CI: 0.01, 0.43), and weight
gain (SMD 0.40; 95% CI: 0.02, 0.78), however, stunting
reduced non-significantly (RR 0.70; 95% CI: 0.49 1.01)
[20]. On the other hand, in food insecure population, CF
education alone significantly improved HAZ scores (SMD
0.25; 95% CI: 0.09, 0.42), WAZ scores (SMD 0.26; 95% CI:
0.12, 0.41) and significantly reduced the rates of stunting
(RR 0.68; 95% CI: 0.60, 0.76), while CF provision with or
without education improved HAZ (SMD 0.39; 95% CI:
0.05, 0.73) and WAZ scores (SMD 0.26; 95% CI: 0.04,
0.48) significantly. Similar results were also reported in an
earlier Lancet review [21].
Prevention and management of childhood malaria
a) Provision and promotion of use of insecticide trea-
ted nets (ITNs) for children
ITNs not only provide a physical barrier to bites from
mosquitoes, but their insecticide component like pyre-
throids also repel and kill them.
A Cochrane review reported 17% protective efficacy (PE)
(RR 0.83, 95% CI 0.76, 0.90) with ITNs when compared
with no nets and 23% PE compared to untreated nets (RR
0.77, 95% CI 0.63, 0.95) and about 5.5 lives (95% CI 3.39,
7.67) can be saved each year for every 1000 children pro-
tected with ITNs [22]. It further reported 18% reduction in
all-cause child mortality (RR 0.82; 95% CI: 0.76, 0.89) [22].
b) Malarial prophylaxis in children:
Intermittent preventive treatment or intermittent pre-
sumptive treatment (IPT) involves giving the drug e.g.
sulfadoxine-pyrimethamine, at full therapeutic dose to
the whole population at risk at specific times to prevent
mortality or morbidity [23].
IPT for malaria in children living in areas with seasonal
transmission showed lower rates of clinical malaria during
intervention (RR 0.26; 95% CI: 0.17, 0.38), and during
post-intervention (RR 0.98; 95% CI: 0.82, 1.17) [24]. The
same review found lower cases of severe malaria during
intervention (RR 0.27; 95% CI:0.10, 0.76), and lower rates
of parasitaemia malaria during intervention (RR 0.35; 95%
CI: 0.25, 0.50) as well as during post-intervention (RR
1.01; 95% CI: 0.89, 1.16) [24]. Artemisinin-based combina-
tion therapies also showed significant results on reducing
malaria in children 1-23 months of age (RR 0.01; 95% CI:
0.00, 0.06); and children 24-59 months (RR 0.03; 95% CI:
0.01, 0.14) [25]. The review also estimated the PE of treat-
ment of severe P. falciparum malaria with effective case
management including intravenous quinine on reducing
malaria mortality in children 1-59 months to be 82%
(range: 63-94%) compared to no treatment [25]. Another
review estimated 55%PE with ITNs and indoor-residual
spray on reducing malaria-attributable mortality in chil-
dren 1-59 months (RR 0.45; 95% CI: 0.39, 0.51) [26].
The use of monthly sulfadoxine-pyrimethamine (SP)
compared to a standard 2-dose SP in HIV-positive preg-
nant women, resulted in non-significant reduction in
maternal anemia (Hb<11g/dl) (RR 0.97, 95% CI0.84, 1.12),
however, presence of malaria in the placental blood (pla-
cental parasitaemia) decreased (RR 0.42; 95% CI: 0.23,
0.76) [27]. No improvements were observed in in neonatal
mortality (RR 0.29; 95% CI: 0.08, 1.05) [27].
Comprehensive care of children infected or exposed to
HIV infection
HIV infection in children (not on antiretroviral therapy
(ART)) follows a more destructive course, with death
occurring in about 30% by the 1st year and 50% by the age
of 2 years [28,29]. Prophylaxis with co-trimoxazole is a
drug of choice for infants who are born to HIV infected
mothers, since the detection of the HIV from birth till
18 months is very difficult due to the presence of maternal
HIV antibodies.
The results of the Cochrane review on administration of
cotrimoxazole prophylaxis vs. placebo found a single trial
from Zambia and the study reported reduction in child
mortality (RR 0.67; 95% CI: 0.53, 0.85), and hospital admis-
sion (RR 0.77; 95%CI: 0.62, 0.96) [28]. Zidovudine (ZDV)
plus lamivudine (3TC) given to mothers from 36 weeks
gestation, during labor and for 7 days after delivery and to
babies for the first 7 days after birth (PETRA ‘regimen A’)
significantly reduced HIV infection (Efficacy 62.75%; 95%
CI: 40.76, 84.74) [30].
Iron supplementation may have a role in reducing mor-
tality and morbidity in HIV infected children, but no ran-
domized controlled trials on the subject were found [31].
Promote and provide routine immunization and
vaccinations in infants/children
Expanded Program on Immunization (EPI) schedule for
poliomyelitis, diphtheria, pertussis, tetanus, measles and
tuberculosis is one of the most cost-effective ways to
improve child health [32]. It has been estimated that over
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3 million deaths are averted each year from measles, per-
tussis and neonatal tetanus by vaccination [33]. Rota-
viruses cause viral gastroenteritis and result in more
deaths from diarrhea in children under 5 years of age than
any other single agent, particularly in LMICs [34]. The
WHO recommends that all children should be vaccinated
with a monovalent rotavirus vaccine or a pentavalent rota-
virus vaccine, with a stronger recommendation for coun-
tries where deaths due to diarrhea comprise more than
10% of all deaths [34]. Immunization against Haemophilus
influenzae type b (Hib) is recommended where resources
permit its use and the burden of disease is established.
WHO considers that pneumococcal conjugate vaccine
should be a priority for inclusion in national childhood
immunization programs. Countries with mortality among
children aged <5 years of >50 deaths/1000 births or with
more than 50,000 children’s deaths annually should make
the introduction of PCV-7 a high priority for their immu-
nization programs.
Rotavirus (RV) vaccines were successful in preventing
severe rotavirus diarrhea and all-cause diarrhea (severe
cases) (RR 0.59; 95% CI: 0.42, 0.83) [34]. Moreover,RV1
vaccine showed better results compared to RV5- (RR 0.20;
95% CI: 0.11, 0.35); [34].Efficacy and safety of three main
types of rotavirus vaccines (bovine, human, and rhesus)
demonstrated results varying from 22 to 89% to prevent
one episode of rotavirus diarrhea, 11 to 44% to prevent
one episode of all-cause diarrhea, and 43 to 90% to pre-
vent one episode of severe rotavirus diarrhea [35]. Cur-
rently marketed rotavirus vaccines can prevent 74% (95%
CI: 35, 90%) of rotavirus deaths and 47-57% of rotavirus
hospitalizations [36].
A recent review on the effect of oral vaccines in terms
of immunogenicity, indicated a greater than two folds
rise in the vibriocidal antibody titres (RR 2.24, 95% CI:
1.32, 3.80); live oral vaccines showed a more significant
rise as compared to killed oral vaccines [37]. A Review by
Das et al. reported that cholera vaccinationwas associated
with a 52% reduction in cholera incidence (RR 0.48, 95%
CI: 0.35, 0.64) while, shigella vaccine had no impact on
reducing the incidence of the disease (RR: 0.72, 95% CI:
0.37, 1.39) [37].
Vitamin A supplementation from 6 months of age in
Vitamin A deficient population
Vitamin A is a term used for a group of fat-soluble com-
pounds required for the growth and differentiation of dif-
ferent body cells [38]. It also acts as an anti-oxidant agent
and is especially involved in regeneration of epithelium of
respiratory and gastrointestinal tracts [39]. Deficiency of
vitamin A makes infant and children susceptible to infec-
tions [40]. Intervention with vitamin A in neonatal period
and in children older than six months of age has shown
reduction in all-cause mortality and cause specific mortality
of diarrhea and measles [21,41].
Recent Cochrane and non-Cochrane reviews reported
significant impact of vitamin A supplementation in redu-
cing mortality due to any unspecified cause (RR 0.75; 95%
CI: 0.65-0.87) [42]; (RR 0.76; 95% CI: 0.69-0.83) [43]; (RR
0.76; 95% CI: 0.69-0.83) [44] as well as mortality due to
diarrhea: (RR 0.68; 95 % CI: 0.57-0.81) [42], (RR 0.72; 95%
CI: 0.57-0.91) [43], (RR 0.72; 95% CI: 0.57-0.91) [44]. The
reviews did not find any impact of vitamin A supplementa-
tion on mortality due to pneumonia, however mortality
due to measles decreased (RR 0.50; 95% CI: 0.37-0.67) [43].
The review by Mayo-Welson et al. 2011 also reported
reduced incidence of diarrhea: (RR 0.85; 95% CI: 0.82-
0.87), vision problems (RR 0.32; 95% CI: 0.21-0.50), and
xerophthalmia (RR 0.31; 95% CI: 0.22-0.45) [44] with
supplementation.
Management of severe acute malnutrition
Severe acute malnutrition (SAM) in children is defined as
having a weight-for-height Z score of <3 according to
WHO growth standards; visible wasting; or the presence of
nutritional edema. It is estimated that malnutrition directly
or indirectly is responsible for 35% of deaths occurring in
children under five, so it is vital to correct malnutrition
globally in order to decrease child mortality [45].
Implementation of the WHO guidelines (that includes
early initiation of fluids, proper feeding, slow oral rehydra-
tion, broad-spectrum antimicrobial therapy and promptly
managing all complications if present) showed reduction
in mortality (RR 0.39; 95%CI: 0.28, 0.53) when compared
with no guidelines. On the other hand, ready to use thera-
peutic food RUTF (a dry, solid diet without any addition
of water so risk of bacterial contamination is eliminated)
showed improvement in weight gain (g/kg/day) (Mean
Difference (MD) 1.36; 95% CI: 0.33, 2.40) when compared
with provision of corn flour in moderately malnourished
children [46]. A recent review reported a reduction (ran-
ged 3.4% to 35%) in case fatality rates among children who
were treated in in-patient using the WHO protocol [47].
For community-based treatment of SAM, children given
RUTF were 51% more likely to achieve nutritional recov-
ery than the standard care group (RR 1.51; 95% CI: 1.04,
2.20) [47].
Case management of childhood pneumonia
About 7.6 million children die every year before they
reach their fifth birthday [48]. The main causes of these
deaths are: acute respiratory infections, diarrhea,
measles, malaria, malnutrition, or often a combination
of these conditions. WHO and UNICEF launched a
strategy, called Integrated Management of Childhood Ill-
ness (IMCI), to reduce deaths due to these manageable
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and preventable causes. IMCI is a strategy to reduce
childhood mortality and morbidity from acute respiratory
infections, diarrhea, measles, malaria, and malnutrition.
Systematic analysis by Theodoratou et al. 2010 found a
significant impact of community case management with
antibiotic on reducing ARI mortality (RR: 0.65; 95% CI:
0.52, 0.82) and all-cause mortality (RR: 0.79; 95% CI: 0.70,
0.88) among children 0-5 years [49]. A relatively older
review also reported similar findings on reducing total
mortality (RR 0.76; 95% CI: 0.67, 0.86) and pneumonia
mortality (RR 0.64; 95% CI: 0.51, 0.80) among children 0-4
years of age [50]. However, a recent pooled analysis of
community based interventions found a significant
increase in care seeking (13%) and a signficant decrease in
treatment failure rates (40%) for pneumonia [51]. The
review also reported beneficial impact of community case
management of pneumonia on reducing pneumonia speci-
fic mortality by 32% [51].
Among children with measles, vitamin A supplementa-
tion had a protective effect on reducing mortality (odds
ratio (OR 0.39; 95% CI: 0.22, 0.66) [52]. Another review
reported that a single dose of measles vaccine can reduce
the incidence ofmeasles disease by 85% [95% CI: 83, 87)
[53]. The stratified data from the same review showed that
among children who were provided with vitamin A (two
doses of 200,000 IU for children >1 year and 100,000 IU
for infants), measles mortality significantly reduced by 62%
(RR 0.38; 95% CI: 0.18,0.81) [53].
Vitamin A as part of treatment for non-measles asso-
ciated pneumonia for children above 6 months showed
thatwhen a high-dose of vitamin A was given along with
standard treatment of acute lower respiratory tract
infection, no significant recovery was seen in children in
developing countries aged from 1 month to 6 years [54].
Other reviews showed no significant reduction in mor-
tality associated with pneumonia in children treated
with vitamin A compared to those who were not (OR
1.29; 95% CI: 0.63, 2.66). Also, there was no significant
difference in duration of hospital stay, and disease sever-
ity after supplementary high-dose vitamin A was signifi-
cantly worse compared with placebo [55].
Grotto et al, on the other hand, indicated that vitamin A
supplementation has no consistent overall protective effect
on the incidence of diarrhea (RR 1.00; 95% CI: 0.94, 1.07)
and that it slightly increases the incidence of respiratory
tract infections (RR 1.08; 95% CI: 1.05, 1.11) [56]. Similarly,
Chen et al. reported that most of the included studies
found no significant effect of vitamin A on the incidence of
acute LRTI, or prevalence of symptoms of acute LRTI [57].
Lamberti et al. indicated that pneumonia mortality was
higher among infants who were not breastfed compared to
exclusively breastfed infants of 0-5 months of age (RR
14.97; 95% CI: 0.67, 332.74) and among not breastfed
compared to breastfed infants and young children 6-23
months of age (RR 1.92; 95% CI: 0.79, 4.68) [58].
Case management of diarrhea
a. Preventive zinc supplementation in children
A number of intervention trials have been conducted in
a variety of settings to assess the impact of preventive zinc
supplementation on children’s health and development.
The results of these studies are inconsistent, possibly
because of differences in the underlying zinc status or
other characteristics of the study populations or discrepan-
cies in the research methods [59,60]. Previous reviews
have shown that preventive zinc supplementation has a
beneficial effect on reduction of incidence of diarrhea,
pneumonia and other infectious diseases [61].
Zinc supplementation in children with diarrhea showed
a decrease in diarrhea specific mortality (RR 0.81; 95% CI:
0.64,1.03), in pneumonia specific mortality (RR 0.86; 95%
CI: 0.66, 1.12) and similar reductions in diarrhea and
pneumonia specific morbidities [62].
b. Therapeutic zinc supplementation in children
Zinc deficiency is one of the leading risk factors for mor-
bidity and mortality [63,64]. It is estimated that zinc defi-
ciency is responsible for approximately 800,000 excess
deaths annually among children under 5 years of age. The
existing literature provides evidence of a beneficial effect
of therapeutic zinc supplementation for the treatment of
diarrhea shown to decrease the duration and severity of
the diarrheal episode, diarrhea hospitalization rates and, in
some studies, all-cause mortality [65].
Zinc supplementation may shorten the duration of diar-
rhea by around 10 hours (MD -10.44 hours; 95% CI:
-21.13 to 0.25). It also reduces the number of children
whose diarrhea persists until day seven (RR 0.73; 95% CI:
0.61 to 0.88), and the duration of persistent diarrhea short-
ens by around 16 hours (MD -15.84 hours; 95% CI: -25.43
to -6.24) [66].
c. ORS for diarrhea in children
Children who lose a large volume of liquid stool may
develop moderate or severe dehydration; in the most
severe cases this can lead to death. These children should
be given rehydration therapy in order to restore the lost
fluids and electrolytes. Oral rehydration solutions (ORS)
have had a massive impact worldwide in reducing the
number of deaths related to diarrhea. Most ORS is in the
form of a sugar-salt solution, but over the years people
have tried adding a variety of compounds (’glucose poly-
mers’) such as whole rice, wheat, sorghum, and maize.
A review by Gregorio et al showed decreased unsched-
uled IV infusions (RR 0.75; 95% CI: 0.59-0.95) with poly-
mer based ORS compared to glucose based ORS [67].
Hartling et al., on the other hand compared ORS therapy
with intravenous therapy and reported significant risk
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difference intreatment failure (RD 4%; 95% CI: 1%, 7%);
and non-significant impact on hospital stay (WMD -1.2;
95% CI: -2.38, 0.02). The same review reported 50 number
needed to treat (NNT) forphelibitis: (95% CI: 25-100); and
33 for paralytic illeus(95% CI: 20, 100) [68]. When reduced
osmolarity ORS was compared with WHO standard ORS,
a reduction in unscheduled IV Infusion was observed (OR
0.59; 95% CI: 0.45, 0.79) [69].
Lenters et al. reported that the co-promotion of zinc and
ORS indicated that mothers were 1.82 (95% CI 1.17, 2.85)
times more likely to treat their child’s diarrhoea episode
than mothers in the comparison group [70]. Mothers who
were exposed to media and social marketing strategies
through radio, television and cinema spots as well as com-
munity outreach activities and print materials were 2.05
(95% CI 0.78, 5.42) times more likely to use ORS to treat
their child’s diarrhoea episode than mothers who were not
exposed [70].
Vomiting due to acute gastroenteritis limits the success
of oral rehydration leading to an increased use of intrave-
nous rehydration, need for prolonged emergency depart-
ment stays and hospitalizations. Das et al. reported that
use of antiemetic in diarrhoea was associated with a signif-
icant 54% reduction in the incidence of vomiting (RR 0.46;
95% CI: 0.35, 0.61) and 54% reduction in the incidence of
hospitalization (RR: 0.46, 95% CI: 0.29, 0.74) [71].
d. Treatment of dysentery in children
Shigellosis occurs predominantly in LMICs and is most
common where overcrowding and poor sanitation exist.
Shigellosis is a bacterial infection of the colon that causes
diarrhea and can lead to death. Dysentery is frequent
mucoid or bloody stools. When dysentery is caused by
Shigella it is called Shigella dysentery. The intention of giv-
ing antibiotics in shigellosis is to speed recovery, reduce
the seriousness of the disease, and reduce the length of
time patients are infective. However, some antibiotics can
have serious side effects while others may not be effective
against the Shigella bacteria.
Reduced episodes of diarrhoea at follow-up were seen
with Furazolidone versus no drug (RR 0.21; 95% CI: 0.09,
0.48) as well as with cotrimoxazole versus no drug (RR
0.30; 95% CI: 0.15, 0.59) [72]. However, treatment with
one of the three WHO-recommended antibiotics (cipro-
floxacin, ceftriaxone and pivmecillinam) resulted in a clini-
cal failure rate of 0.1% (95% CI: −0.2, 0.5%) [73]. On the
other hand, when two different antibiotics (Pivmecillinam
and Ciprofloxacin) were used it resulted in 82% reduction
in clinical failure (RR 0.18; 95% CI: 0.10, 0.33). While Piv-
mecillinam, Ciprofloxacin and Ceftriaxone reported 96%
reduction in bacteriological failure of (RR 0.04; 95% CI:
0.01, 0.12) [74].
f. Treatment of cholera in children
Cholera is caused by ingesting food or water containing
the bacterium Vibrio cholera. The disease can spread
rapidly among populations lacking access to safe water
and adequate sanitation facilities. Symptoms of cholera
include acute watery diarrhea, vomiting, and severe dehy-
dration, which can lead to death within 24 hours if left
untreated [75]. Because cholera is associated with signifi-
cant electrolyte loss especially among children, the use of
ORS with reduced sodium levels may place patients at a
greater risk for developing biochemical hyponatremia (low
blood sodium levels <130mmol/L) [76], which can result
in severe illness including seizures, respiratory arrest,
coma (symptomatic hyponatremia), and even death.
For glucose-based ORS, biochemical hyponatraemia
(blood sodium levels <130mmol/L) was more common
with ORS ≤270 (RR 1.67, 95% CI 1.09, 2.57), while a
higher level of severe biochemical hyponatraemia (blood
sodium levels <125mmol/L) in the same group was not
significant (RR 1.58, 95% CI 0.62, 0.04). In the ORS
≤270 group (rice base ORS) , duration of diarrhoea was
shorter (MD -11.42 hours, 95% CI -13.80, -9.04) [77].
The antibiotic treatment of cholera showed 63% reduc-
tion in clinical failure (RR 0.37; 95% CI: 0.19, 0.71) [74].
Discussion
The threat to child survival continues to be of grave
concern. Therefore, this paper summarizes all the essen-
tial preventive and therapeutic child health interventions
for preventing illnesses and improving child survival.
The importance of these interventions have been
addressed in previous publications [78-82] and more
recently in the Lancet Neonatal Series [83]. However
this review progresses further by collating and analyzing
existing evidence to assist health professionals and pol-
icy makers reduce the current burden of child morbidity
and mortality.
What cannot be stressed enough is the importance of
exclusive breastfeeding of children till at least the age of
6 months; this ensures proper growth and development of
the child. To prevent growth faltering or a decline in the
child’s motor and physical development, continued breast-
feeding is an intervention that is being implemented in
many regions where mothers may be substituting poor
quality weaning foods in place of breastfeeding. It should
also be noted that poverty and poor water and sanitary
conditions are some of the underlying causes of poor child
growth and development and infection- specific mortality;
and that, breastfeeding, alone, cannot contribute in
improving health and survival. Therefore, promotion of
breastfeeding should be implemented in conjunction with
a larger strategy that includes promotion of complemen-
tary feeding, improved water and sanitation, and better
health care services.
Interventions to target the main causes of under-five
mortality including pneumonia, diarrhea, malaria and
under nutrition is the key to further success in bringing
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down child mortality. Interventions including antibiotics,
ITNs, and improved family care need to be implemented
to further reduce child morbidity and mortality rates. In
endemic regions or tropical areas, malarial prophylaxis is
vital; the expanded program on immunization (EPI) has
been and will continue to be one of the most cost effective
methods of improving mortality and morbidity rates. Evi-
dence suggested that ITN use can reduce child mortality
by 18% and 5.5 lives can be saved annually for every 1000
children between 1-59 months protected. In areas with
seasonal transmission, IPT showed a dramatic decrease in
clinical malaria during intervention, as well as rates of
parasitemia post intervention. However, long-term follow-
up studies are needed for efficacy of IPT use in children,
including its safety.
Preventive zinc supplementation shows promising bene-
fits in reducing diarrhea specific mortality but further sup-
porting data is required. On the other hand, therapeutic
zinc supplementation has a beneficial effect on reducing
duration and severity of acute and persistent diarrhea. The
results indicate that scaling up the use of zinc in health sys-
tems is feasible particularly in LMICs. However, the evi-
dence for beneficial effect of zinc in the treatment of
pneumonia, malaria and tuberculosis is limited and needs
further evaluation. There are a number of available oppor-
tunities to deliver zinc supplementation as one component
of programs to prevent micronutrient deficiencies and to
address other nutrition and health needs of infants and
children. Efforts are needed to test these delivery mechan-
isms and evaluate their potential for providing cost-effective
preventive zinc supplementation to high-risk target groups
on a large scale.
Multi-country evaluation of implication of IMCI has
shown that it has been very effective in reducing the mor-
tality and morbidity from ARI, diarrhea, measles and mal-
nutrition. It is cost effective and applicable on larger scale.
Considering the strengths of the IMCI strategy and the
existing commitments and investments by countries, the
IMCI strategy, should be continued and expanded, as part
of a broader investment approach to improve child health
outcomes. Vitamin A supplementation in children after
six months of age reduces all-cause mortality and diarrhea
specific and measles specific mortality. There is a very lim-
ited evidence for protective effect of vitamin A for preven-
tion of pneumonia specific mortality and morbidity. Due
to its beneficial effect on all-cause and diarrhea-specific
mortality, routine vitamin A supplementation in this age
group is recommended.
As we move closer to the deadline for the target of the
MDGs, a closer look at the existing programs and inter-
ventions was necessary to evaluate where opportunities for
improvement lie. This paper is a comprehensive and thor-
ough summary of essential child health interventions and
can be used by health professionals and decision makers
from the field. The strength of this paper lies in the fact
that it includes and summarizes evidence from all recent
Cochrane and non-Cochrane reviews on child health
interventions. However, at times the quality of all included
studies within the review could not be ensured which lim-
its the quality of the data obtained.
Conclusion
High rates of child mortality are unquestionably linked
to inadequate and poor quality health services available
in the early years of life both to mother and child. In a
majority of countries, especially low-income countries,
the availability of health care services, vaccination pro-
grams and other vital amenities are inadequate, of poor
quality, and require positive transformation. Because a
major proportion of child deaths occur in LMICs, the
need for appropriate education and awareness is vital
prior to establishing interventions. Empowerment of
women, removing barriers to accessibility to health care
services, increased education and awareness in commu-
nities, and shifting the focus to evidence based interven-
tions may help inculcate healthy practices among
mothers and improve child survival rates. Appropriate
culturally sensitive education and awareness provided to
the communities, followed by timely implementation of
discussed interventions which can be infused with exist-
ing healthcare practices, will definitely bring the
required improvement in child health and survival.
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